A carregar...
Targeting Malignant Brain Tumors with Antibodies
Antibodies have been shown to be a potent therapeutic tool. However, their use for targeting brain diseases, including neurodegenerative diseases and brain cancers, has been limited, particularly because the blood–brain barrier (BBB) makes brain tissue hard to access by conventional antibody-targeti...
Na minha lista:
| Publicado no: | Front Immunol |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Frontiers Media S.A.
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5622144/ https://ncbi.nlm.nih.gov/pubmed/28993773 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2017.01181 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|